KCT-0809

DRUG3 trials

Sponsors

Kissei Pharmaceutical Co., Ltd.

Conditions

Dry Eye Syndromes

Phase 2

A Study of KCT-0809 in Patients With Dry Eye Syndromes

CompletedNCT01211951

Kissei Pharmaceutical Co., Ltd.Dry Eye Syndromes

Target: 160Updated: 2011-07-04

A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome

CompletedNCT01427816

Kissei Pharmaceutical Co., Ltd.Dry Eye Syndromes

Target: 180Updated: 2013-10-30

A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

CompletedNCT01692145

Kissei Pharmaceutical Co., Ltd.Dry Eye Syndromes

Updated: 2014-05-30